I'm an investor in IMGN which SBH is now partnering with for a major cancer curing drug. The partnership has taken years to consummate and now that it's done IMGN has gained little in stock price in spite of the fact that it could be a great partnership for both companies.
The reason IMGN's seen little movement in general is being blamed on a general lack of information and P.R. As I understand it, IMGN's hands are tied by the agreement as to what they can say.
My question to those here is why isn't SBH saying more?
They have gained the right to a drug that could cure Colon, Pancreatic, and Lung (non small cell) Cancers the right way. What I mean by that is if the tumor is small enough no surgery at all should be required, no chemo, no radiation, just injections of our drug. If the tumor is large I understand the bulk of the tumor may have to be removed, but it would not be critical to get all the tumor as the drug will eliminate any remaining tumor or cancerous cells. The removal as I understand it is to not flood the body with more toxins than it can handle, as the drug kills the cancerous cells, the remains are toxic and are removed by the bodies normal cleansing mechanisms. I don't have a medical background, but I suspect a procedure similar to arthroscopic surgery may be what would be required.
Their are no guarantees the drug will work, but if it does it could well be the last drug needed for those types of cancer as what could possibly be a better way to cure them. Their are also additional cancers that the drug should work on as well.
As investors in SBH I would think you'd like to know more and I hope you'll help IMGN get the word out about the potential blockbuster drug that we're developing.
Hope to hear from you later,
Gary |
